Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Skye Bioscience Inc SKYE

Healthcare Biotechnology
Skye Bioscience, Inc. is a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel classes of therapeutic drugs that modulate the endocannabinoid system. The Company's clinical assets focus on the modulation of cannabinoid receptor 1 (CB1) to provide novel treatments and alternatives for diseases caused by metabolic disorders, inflammation... see more

Recent & Breaking News (NDAQ:SKYE)

NEMUS Announces Research Agreement With the University of Mississippi to Develop Proprietary Cannabidiol (CBD) Molecules

Marketwired July 7, 2015

NEMUS Bioscience, Inc. to Present on Cannabis Investor Webcast

Accesswire June 3, 2015

NEMUS Bioscience Announces Appointment of Douglas S. Ingram, Former President of Allergan, to Its Board of Directors

Marketwired June 1, 2015

NEMUS Bioscience, Inc. to Attend Upcoming Investment Conferences

Marketwired May 15, 2015

NEMUS Bioscience, Inc. to Present on Cannabis Investor Webcast

Accesswire April 8, 2015

NEMUS Bioscience, Inc. to Present at Cannabis Investor Webcast

Accesswire March 10, 2015

Nemus Unlocks Cannabinoid Potential with Unique Compound

Accesswire February 17, 2015

StockNewsNow.com Publishes New SNNLive Video Interview with NEMUS Bioscience, Inc.

Accesswire February 11, 2015

NEMUS Bioscience, Inc. to Present at Cannabis Investor Webcast

Accesswire January 22, 2015

NEMUS Bioscience Announces Appointment of Thomas A. George, CFO of Deckers Brands, to Its Board of Directors

GlobeNewswire January 12, 2015

NEMUS to Move Forward With Cannabinoid-Based Therapy for Open-Angle Glaucoma

GlobeNewswire December 4, 2014

NEMUS Bioscience Is Now Quoted on the OTC Bulletin Board Under the Ticker Symbol of "NMUS"

Business Wire November 26, 2014

NEMUS Completes Reverse Merger With Load Guard Logistics, Inc.

Business Wire November 4, 2014